Founded in 1992 by senior executives with entrepreneurial, line operating, and bulge bracket investment banking experience.
During the month of March 2010, Avalon, as the sole placement agent, raised Frederick's of Hollywood Group Inc. $3mm in common stock and warrants.
|
|
|
| Client |
Transaction Description ($mm) |
|
| 2009 August - Cytomedix, Inc. (NYSE Alternext:GTF) |
| $1,470,000 Common Stock with Warrants - Registered Direct |
|
|
|
|
|
|
Avalon worked as the sole placement agent for Cytomedix, Inc. to raise a total of $1.47mm in common stocks with warrants via a registered direct offering with several institutional investors and current shareholders. Proceeds used for general working capital.
Cytomedix, Inc. is a biotechnology company that develops, sells and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation and angiogenesis. |
| AMDL, Inc. (NYSE Alternext: ADL)* |
| $7mm Common Stock with Warrants |
|
|
|
|
|
|
AMDL, Inc. (NYSE Alternext: ADL) Worked with the management team to secure over $7mm in common stock with warrants equity financing from several institutional investors to expand AMDL's over the counter generic drug and beauty cosmetics product divisions. (*)Spencer Clarke was sole placement agent.
AMDL, Inc.is a vertically integrated specialty pharmaceutical company with three distinct business divisions that include In-Vitro diagnostics, China-based pharmaceutical manufacturing and distribution and cancer therapeutics. These business units focus on the development, manufacturing, distribution and sales of medical diagnostic products, generic pharmaceuticals, nutritional supplements, and cosmetics in the United States, China, Korea, Taiwan and other markets. |
| Chembio Diagnostics (OTCBB:CEMI)* |
| $8.15mm Convertible Preferred Stock with Warrants - Private Placement |
|
|
|
|
|
|
Chembio Diagnostics (OTCBB:CEMI) Avalon's Capital Markets Co-Presidents worked with the management to raise $1.0mm in convertible preferred stock with warrants via private placement with several institutional investors. Proceeds used for general corporate purposes including for sales and marketing, research and development, and intellectual property, and working capital. (*)Midtown Partners & Co. was sole placement agent.
Chembio Diagnostics, Inc., along with its subsidiaries, develops, manufactures and markets diagnostic tests that detect infectious diseases. |
| Cleveland BioLabs (NASDAQ: CBLI)* |
|
Cleveland BioLabs (NASDAQ: CBLI) Consulted with company on strategic initiatives including organizing non deal road show, partnering and licensing opportunities and valuation analysis. (*)Spencer Clarke was sole advisor.
Cleveland BioLabs, Inc. (CBLI) is a development-stage biotechnology company. The Company is focused on developing cancer treatment, tissue protection and biodefense drugs. |
| Cytomedix (NYSE Alternext: GTF)* |
|
Cytomedix (NYSE Alternext: GTF) Worked with the management team to introduce the company to institutional investors and strategic advisors during a non-deal road show in New York and Chicago. Assisted with drafting investor presentation for healthcare conference. (*)Spencer Clarke was sole advisor.
Cytomedix, Inc. (Cytomedix) is a biotechnology company that develops, sells and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation and angiogenesis. |
| Pacific Biometrics (OTCBB:PBME)* |
| $3.8mm Common Stock with Warrants - Private Placement |
|
|
|
|
|
|
Pacific Biometrics (OTCBB:PBME) Avalon's Capital Markets Co-Presidents worked with the management to raise a total of $3.8mm in common stock with warrants via private placement with several institutional investors. Proceeds used for general corporate purposes including working capital. (*)Midtown Partners & Co. was sole placement agent.
Pacific Biometrics, Inc. provides specialty central laboratory services to support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research, for use in their drug and diagnostic product development efforts. |
| Vetco, Inc. |
| Valuation of Minority Interest in Private Company |
|
|
|
|
|
|
| Appointed by the Supreme Court of the State of New York, County of Nassau as a neutral expert to value a minority shareholder's ownership after a rescinded 1996 Initial Public Offering. Vetco developed and distributed pediatric over-the-counter healthcare products including Little NosesŪ nasal products, Little TummysŪ digestive health products, Little ColdsŪ cough/cold remedies and Little Remedies New Parents Survival Kits. In 2004, Vetco was acquired by Prestiges Brands, Inc. |
|
|
|
|
|
|
